Evidence map›Paper›PMID 24039253›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2013

Thrombin selectively engages LIM kinase 1 and slingshot-1L phosphatase to regulate NF-κB activation and endothelial cell inflammation.

Antony Leonard, Catherine Marando, Arshad Rahman, Fabeha Fazal

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Disulfidptosis modification patterns are involved in the immune microenvironment regulation of septic acute respiratory distress syndrome.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Phospholipase C-ε signaling mediates endothelial cell inflammation and barrier disruption in acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Novel regulators of endothelial barrier function.American journal of physiology. Lung cellular and molecular physiology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antony LeonardDept. of Pediatrics, Lung Biology and Disease Program, Univ. of Rochester School of Medicine, 601 Elmwood Ave./Box 850, Rochester, NY. fabeha_fazal@urmc.rochester.edu.
Catherine Marando
Arshad Rahman
Fabeha Fazal
University of Rochester · US

Funding

G-protein-induced Signaling of PMN-mediated Lung InjuryR01HL067424 · NHLBI · UNIVERSITY OF ROCHESTER · PI RAHMAN, ARSHAD · 2002 to 2010
$2.3M
Regulation of Endothelial ICAM-1 and PMN-Mediated Lung Injury by Actin DynamicsR01HL096907 · NHLBI · UNIVERSITY OF ROCHESTER · PI FAZAL, FABEHA · 2010 to 2014
$1.5M
Regulation of Lung Authopagy and InflammationR01HL116632 · NHLBI · UNIVERSITY OF ROCHESTER · PI RAHMAN, ARSHAD · 2013 to 2016
$1.5M
NHLBI NIH HHS HL096907NHLBI NIH HHS HL116632NHLBI NIH HHS HL67424NHLBI NIH HHS R01 HL096907NHLBI NIH HHS R01 HL116632
6 · The paper itself

Abstract

Endothelial cell (EC) inflammation is a central event in the pathogenesis of many pulmonary diseases such as acute lung injury and its more severe form acute respiratory distress syndrome. Alterations in actin cytoskeleton are shown to be crucial for NF-κB regulation and EC inflammation. Previously, we have described a role of actin binding protein cofilin in mediating cytoskeletal alterations essential for NF-κB activation and EC inflammation. The present study describes a dynamic mechanism in which LIM kinase 1 (LIMK1), a cofilin kinase, and slingshot-1Long (SSH-1L), a cofilin phosphatase, are engaged by procoagulant and proinflammatory mediator thrombin to regulate these responses. Our data show that knockdown of LIMK1 destabilizes whereas knockdown of SSH-1L stabilizes the actin filaments through modulation of cofilin phosphorylation; however, in either case thrombin-induced NF-κB activity and expression of its target genes (ICAM-1 and VCAM-1) is inhibited. Further mechanistic analyses reveal that knockdown of LIMK1 or SSH-1L each attenuates nuclear translocation and thereby DNA binding of RelA/p65. In addition, LIMK1 or SSH-1L depletion inhibited RelA/p65 phosphorylation at Ser(536), a critical event conferring transcriptional competency to the bound NF-κB. However, unlike SSH-1L, LIMK1 knockdown also impairs the release of RelA/p65 by blocking IKKβ-dependent phosphorylation/degradation of IκBα. Interestingly, LIMK1 or SSH-1L depletion failed to inhibit TNF-α-induced RelA/p65 nuclear translocation and proinflammatory gene expression. Thus this study provides evidence for a novel role of LIMK1 and SSH-1L in selectively regulating EC inflammation associated with intravascular coagulation.

Indexed as

Cell LineCofilin 1Disseminated Intravascular CoagulationEndothelial CellsGene Knockdown TechniquesHumansI-kappa B KinaseLim KinasesNF-kappa BPhosphoprotein PhosphatasesPhosphorylationPneumoniaPulmonary ArteryThrombinTranscription Factor RelAVasculitisCFL1 protein, humanCofilin 1I-kappa B KinaseLIMK1 protein, humanLim KinasesNF-kappa BPhosphoprotein PhosphatasesRELA protein, humanSSH1 protein, humanThrombinTranscription Factor RelAadhesion moleculescytoskeletonendothelial cellsinflammationsignal transductiontranscription factors

Identifiers

PMID24039253
PMCPMC3840277
OpenAlexW2112308482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.